Ignite Creation Date:
2025-12-24 @ 3:36 PM
Ignite Modification Date:
2025-12-27 @ 12:07 PM
Study NCT ID:
NCT07208292
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-10-06
First Post:
2025-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real-world Study on Preoperative Application of Rezvilutamide
Sponsor:
Shanghai Pudong New Area Gongli Hospital
Organization:
Study Overview
Official Title:
Real-world Study on Preoperative Application of Rezvilutamide
Status:
NOT_YET_RECRUITING
Status Verified Date:
2025-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RWS-GU001
Brief Summary:
Real-world study on Preoperative Application of Rezvilutamide
Detailed Description:
Observation on Postoperative and Long-term Indicators of Rezvilutamide in Perioperative Medication, Including Postoperative Pathological Complete Response Rate, Postoperative Biochemical Recurrence, etc.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| mierxiati@fudan.edu.cn | OTHER | Shanghai Pudong New Area Gongli Hospital | View |